Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
47 studies found for:    " January 27, 2010":" February 26, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection
Condition: HIV Infection
Intervention: Drug: Minocycline
22 Completed Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
Condition: HIV Infections
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
23 Completed The Impact of Short Message Services (SMS) on ARV Adherence in Western Kenya
Conditions: AIDS;   Antiretroviral Therapy;   Medication Adherence;   HIV Infections
Intervention: Behavioral: Short Message Services to Support ARV therapy adherence
24 Unknown  Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir; Abacavir/Lamivudine
25 Completed
Has Results
Post-Licensure Safety Study of ISENTRESS™ (Raltegravir) in a United States Managed Care Network (MK-0518-268)
Condition: HIV-1 Infections
Intervention:
26 Completed
Has Results
Special Investigation of Kaletra in Pregnant Women
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
27 Completed
Has Results
Drug Use Investigation of Kaletra
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
28 Completed Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza
Condition: HIV
Intervention: Biological: Foceteria® (Novartis)
29 Completed Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy
Conditions: HIV Infection;   Antiretroviral Side Effects;   Lipodystrophy Syndrome Related to HIV Infection
Intervention: Device: Eutrophill
30 Completed PENTA Fosamprenavir Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Exposure to licensed dose of FPV (+/- 20% of 18mg/kg BID + RTV)
31 Completed
Has Results
Evaluation of Kaletra Therapy Over the Long-term
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
32 Completed Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet
Condition: Human Immunodeficiency Virus
Intervention:
33 Completed Kaletra in Combination With Antiretroviral Agents
Condition: Human Immunodeficiency Virus
Intervention:
34 Completed
Has Results
Kaletra: Therapy With Double Protease Inhibitors
Condition: Human Immunodeficiency Virus
Intervention:
35 Completed
Has Results
Cryptococcal Optimal ART Timing Trial
Conditions: Cryptococcal Meningitis;   HIV Infections;   AIDS
Interventions: Drug: efavirenz;   Biological: nucleoside
36 Completed
Has Results
Observational Data Analysis in EuroSIDA (MK-0518-058)
Condition: HIV-1 Infections
Intervention:
37 Completed Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV
Conditions: Tuberculosis;   HIV
Interventions: Dietary Supplement: Immunoxel;   Other: Placebo
38 Completed
Has Results
Surveillance of Kaletra in Korean Patients
Condition: HIV-1 Infection
Intervention:
39 Completed
Has Results
Long-term Effectiveness and Safety in Hepatitis-co-infected Patients
Condition: Human Immunodeficiency Virus-Infection
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
40 Completed
Has Results
Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Condition: Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Intervention: Biological: Serostim

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-47) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.